Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Your Editor On Twitter

Jun 27 2014 - FYI

This week’s Tweets on Twitter by Your Editor.


Australian Corporate Bond Price Tables

Jun 27 2014 - Australia

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.


Australian Stocks: What Happened Today?

Jun 26 2014 - Australia

A wrap of the day’s activity on the Australian stock market.


SMSFundamentals: SMSF Trustees Becoming Younger And Richer And Looking Offshore

Jun 26 2014 - SMSFundamentals

Traditional near-retirement investors are falling as a proportion of SMSF trustees as a younger demographic seeks to control its own investment destiny, CoreData has found.


Collins Foods Reveals KFC Has The Sizzle

Jun 26 2014 - Small Caps

Collins Foods reveals growth in the KFC franchise was offset by declines in the Sizzler chain in FY14.


The Short Report

Jun 26 2014 - Australia

FNArena’s weekly update on short positions in the Australian share market.


Genworth Attractive But Not Without Risk

Jun 26 2014 - Australia

Brokers offer their outlooks for recently listed Genworth Mortgage Insurance.


Australian Stocks: What Happened Today?

Jun 25 2014 - Australia

A wrap of the day’s activity on the Australian stock market.


Merck Backs Bionomics On Alzheimer’s

Jun 25 2014 - Small Caps

Bionomics has entered a potentially valuable deal as global Pharma giant Merck stumps up all development costs for the company’s Alzheimer’s drug.


The Australian Production Phase And Resultant Currency Impact

Jun 25 2014 - Australia

Australia’s resource sector is shifting into a production phase from an investment phase which should suggest upward pressure on the Aussie dollar from increased exports, but ANZ argues this is not necessarily the case.


Analyse The Market From A Different Angle